Domine Gomez, Manuel manuel.domine@uam.es
Actividades
- Artículos 38
- Libros 1
- Capítulos de libro 0
- Congresos 0
- Documentos de trabajo 0
- Informes técnicos 0
- Proyectos de investigación 0
- Tesis dirigidas 0
- Patentes o licencias de software 0
Multidisciplinary Thoracic Tumors Board Survey in Spain
- Massuti, B
- Nadal, E
- Camps, C
- Carcereny, E
- Cobo, M
- Domine, M
- Garcia-Campelo, MR
- Gonzalez-Larriba, JL
- Guirado, M
- Hernando-Trancho, F
- Rodriguez-Abreu, D
- Sanchez, A
- Sullivan, I
- Provencio, M
Journal Of Thoracic Oncology (p. S107-S107) - 1/9/2022
- ISSN 15560864
- iMarina
Multimodal prediction of response to neoadjuvant nivolumab and chemotherapy for surgically resectable stage IIIA non-small cell lung cancer.
- Ferrer, L
- Nadal, E
- Guidel, F
- Insa, A
- Menu, P
- Casal, J
- Domine, M
- Massuti, B
- Majem, M
- Martinez-Marti, A
- Campelo, RG
- Carpeon, JD
- Cobo, M
- Vivanco, GL
- del Barco, E
- Bernabe, R
- Vinolas, N
- Barneto, I
- Colin, T
- Provencio-Pulla, M
Journal Of Clinical Oncology - 1/6/2022
- ISSN 0732183X
- iMarina
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: A phase Ib/randomized phase II trial
- Weiss JM, Csoszi T, Maglakelidze M, Hoyer RJ, Beck JT, Domine Gomez M, Lowczak A, Aljumaily R, Rocha Lima CM, Boccia RV, Hanna W, Nikolinakos P, Chiu VK, Owonikoko TK, Schuster SR, Hussein MA, Richards DA, Sawrycki P, Bulat I, Hamm JT, Hart LL, Adler S, Antal JM, Lai AY, Sorrentino JA, Yang Z, Malik RK, Morris SR, Roberts PJ, Dragnev KH, G1T28-02 Study Group
Annals Of Oncology (p. 1613-1621) - 1/10/2019
10.1093/annonc/mdz278 Ver en origen
- ISSN 09237534
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
- Sanchez-Herrero, Estela
- Serna-Blasco, Roberto
- Ivanchuk, Vadym
- Garcia-Campelo, Rosario
- Gomez, Manuel Domine
- Sanchez, Jose M.
- Massuti, Bartomeu
- Reguart, Noemi
- Camps, Carlos
- Sanz-Moreno, Sandra
- Calabuig-Farinas, Silvia
- Jantus-Lewintre, Eloisa
- Arnal, Magdalena
- Fernandez-Orth, Dietmar
- Calvo, Virginia
- Gonzalez-Rumayor, Victor
- Provencio, Mariano
- Romero, Atocha;
Molecular Oncology (p. 2363-2376) - 1/9/2021
10.1002/1878-0261.13033 Ver en origen
- ISSN 15747891
NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases
- Nadal, E
- Cantero, A
- Ortega, AL
- Domine, M
- Barba, A
- Blasco, A
- Garcia, J
- Mosquera, J
- Vazquez, S
- Rodriguez, D
- Lopez-Castro, R
- Juan Vidal, O
- Sanchez, A
- Paz Ares, L
- Hernandez, A
- Iranzo, P
- Diz, P
- Provencio, M
- Simo, M
- Navarro, V
- Bruna, J
Journal Of Thoracic Oncology (p. S350-S351) - 1/9/2022
- ISSN 15560864
- iMarina
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)
- Provencio M
- Serna-Blasco R
- Nadal E
- Insa A
- García-Campelo MR
- Casal Rubio J
- Dómine M
- Majem M
- Rodríguez-Abreu D
- Martínez-Martí A
- De Castro Carpeño J
- Cobo M
- López Vivanco G
- Del Barco E
- Bernabé Caro R
- Viñolas N
- Barneto Aranda I
- Viteri S
- Pereira E
- Royuela A
- Calvo V
- Martín-López J
- García-García F
- Casarrubios M
- Franco F
- Sánchez-Herrero E
- Massuti B
- Cruz-Bermúdez A
- Romero A
Journal Of Clinical Oncology (p. 2924-2933) - 1/5/2022
10.1200/jco.21.02660 Ver en origen
- ISSN 0732183X
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
- Wu, YL
- John, T
- Grohe, C
- Majem, M
- Goldman, JW
- Kim, SW
- Kato, T
- Laktionov, K
- Vu, HV
- Wang, ZJ
- Lu, S
- Lee, KY
- Akewanlop, C
- Yu, CJ
- de Marinis, F
- Bonanno, L
- Domine, M
- Shepherd, FA
- Zeng, LM
- Atasoy, A
- Herbst, RS
- Tsuboi, M
Journal Of Thoracic Oncology (p. 423-433) - 1/3/2022
10.1016/j.jtho.2021.10.014 Ver en origen
- ISSN 15560864
RET Fusion Testing with FISH and Real-Time PCR: a Comparison with RNA-Based Next-Generation Sequencing in RET Positive NSCLC
- Hernandez, S
- Carrillo, JLR
- Caminoa, A
- Benito, A
- Martinez, R
- Alonso, M
- Clave, S
- Arriola, E
- Esteban-Rodriguez, I
- De Castro, J
- Sansano, I
- Felip, E
- Abdulkader, I
- Garcia, J
- Rojo, F
- Domine, M
- Teixido, C
- Reguart, N
- Compan, D
- Insa, A
- Mancheno, N
- Palanca, S
- Juan, O
- Baixeras, N
- Nadal, E
- Cebollero, M
- Calles, A
- Martin, P
- Salas, C
- Provencio, M
- Aranda, I
- Massuti, B
- Lopez-Vilaro, L
- Majem, M
- Garrido, P
- Paz-Ares, L
- Lopez-Rios, F
- Conde, E
Journal Of Thoracic Oncology (p. S135-S136) - 1/9/2022
- ISSN 15560864
- iMarina
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
- Levy, B.P.
- Giaccone, G.
- Besse, B.
- Felip, E.
- Garassino, M.C.
- Domine Gomez, M.
- Garrido, P.
- Piperdi, B.
- Ponce-Aix, S.
- Menezes, D.
- MacBeth, K.J.
- Risueño, A.
- Slepetis, R.
- Wu, X.
- Fandi, A.
- Paz-Ares, L.
European Journal Of Cancer (p. 120-128) - 1/2/2019
Editor: Elsevier Ltd
10.1016/j.ejca.2018.11.028 Ver en origen
- ISSN 09598049
- ISSN/ISBN 1879-0852
SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015
- María Rosario García Campelo
- R Bernabé
- Manuel Cobo Dols
- J Corral
- Juan Coves
- Manuel Dómine Gómez
- E Nadal
- Delvys Rodríguez Abreu
- Núria Viñolas Segarra
- Bartomeu Massuti Sureda
Clinical & Translational Oncology (p. 1020-1029) - 1/1/2015
- ISSN 1699048X
- iMarina
Este/a investigador/a no tiene capítulos de libro.
Este/a investigador/a no tiene congresos.
Este/a investigador/a no tiene documentos de trabajo.
Este/a investigador/a no tiene informes técnicos.
Este/a investigador/a no tiene proyectos de investigación.
Este/a investigador/a no tiene tesis dirigidas.
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id